The most important benefit of the Partnership is directed towards people with NCDs and particularly diabetes and hypertension along with their families and communities by saving their lives, maintaining their healthy functioning, and securing their livelihoods. A critical benefit concerns reduction of the out-of-own-pocket expenditure of people who need life-long treatment and often get catastrophically impoverished as a consequence. 100 million people around the world fall below the poverty line every year as a result of crippling medical bills.
For health services, the capacity building component concerned with enhancing the quality of prevention and care brings greater effectiveness and efficiency for the scarce resources that countries have at their disposal, through reducing wastage from misused medication and diagnostics, and achieving better clinical outcomes.
For the governments of low income countries faced with the escalating burden of NCDs, this initiative reduces the overall burden of conditions that generate major social and economic costs, while enhancing the productivity of the NCD-affected labour force and getting better returns from the ‘sunk costs’ of their education and training.